NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Phase III Trial to Study Combination of Genentech's Actemra

Federal Response to COVID-19: Therapeutics CIG

Management of Patients With COVID-19

Management of Patients With COVID-19

Guidelines for COVID-19 Management in Hematopoietic Cell

Therapeutic Management of Nonhospitalized Adults With COVID-19

Remdesivir - Wikipedia

Comparative therapeutic efficacy of remdesivir and combination

VEKLURY® (remdesivir) Educational Videos

Two Years into the COVID-19 Pandemic: Lessons Learned

COVID-19 in people with rheumatic diseases: risks, outcomes

Remdesivir against COVID-19 and Other Viral Diseases

Remdesivir COVID-19 Treatment Guidelines

13 Things To Know About Paxlovid, the Latest COVID-19 Pill > News

The Incidence, Severity, and Management of COVID-19 in Critically